Literature DB >> 2927672

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

M H Brooke1, G M Fenichel, R C Griggs, J R Mendell, R Moxley, J Florence, W M King, S Pandya, J Robison, J Schierbecker.   

Abstract

Two-hundred eighty-three boys with Duchenne dystrophy and 10 with Becker dystrophy have been followed for up to 10 years in a protocol that accurately measured their function, strength, contractures, and back curvature. Clinical heterogeneity is noted. Patients whose muscles were stronger were more likely to die from a cardiomyopathy. Weaker patients died from respiratory failure. A series of milestones is defined, which is of use in following the illness in an individual patient. This approach permits a scoring system that allows the severity of the disease to be defined in an individual boy. Evaluation of physical therapy and surgical intervention shows that night splints and scoliosis surgery are effective forms of treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2927672     DOI: 10.1212/wnl.39.4.475

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  68 in total

1.  Spinal fusion in patients with Duchenne's muscular dystrophy and a low forced vital capacity.

Authors:  A Marsh; G Edge; J Lehovsky
Journal:  Eur Spine J       Date:  2003-05-14       Impact factor: 3.134

2.  Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Emma Tabe Eko Niba; Hiroyuki Awano; Tomoko Lee; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2015-04-02       Impact factor: 3.172

3.  The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy.

Authors:  Rolando Roberto; Anto Fritz; Yolanda Hagar; Braden Boice; Andrew Skalsky; Hosun Hwang; Laurel Beckett; Craig McDonald; Munish Gupta
Journal:  Spine (Phila Pa 1976)       Date:  2011-07-01       Impact factor: 3.468

Review 4.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

Review 5.  Prevention and management of limb contractures in neuromuscular diseases.

Authors:  Andrew J Skalsky; Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

6.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Sean C Forbes; Sunita Mathur; Sean A Germain; Claudia R Senesac; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-04-13       Impact factor: 4.296

7.  Paravertebral muscles in disease of the cervical spine.

Authors:  S B Wharton; K K Chan; J D Pickard; J R Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 8.  Duchenne muscular dystrophy: gene and gene product; mechanism of mutation in the gene.

Authors:  R G Worton
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.

Authors:  Isabelle Desguerre; Christo Christov; Michele Mayer; Reinhard Zeller; Henri-Marc Becane; Sylvie Bastuji-Garin; France Leturcq; Catherine Chiron; Jamel Chelly; Romain K Gherardi
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

Review 10.  Eccentric exercise in aging and diseased skeletal muscle: good or bad?

Authors:  Richard M Lovering; Susan V Brooks
Journal:  J Appl Physiol (1985)       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.